Biodesix (BDSX)

• Market cap: $42M
• 1 day: -4.40%
• 5 days: -1.41%
• 1 month: -20.16%
• 3 months: -61.43%
• 6 months: -78.60%
• Year to date: -80.63%
• 1 year: -81.85%
• 5 years: -97.76%
• 10 years: -97.76%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Employees: 273

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

2% more funds holding

Funds holding: 59 [Q4 2024] → 60 (+1) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

3.76% less ownership

Funds ownership: 40.33% [Q4 2024] → 36.57% (-3.76%) [Q1 2025]

30% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 20

63% less capital invested

Capital invested by funds: $89.7M [Q4 2024] → $33.4M (-$56.3M) [Q1 2025]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $1.50 423% upside
• Avg. target: $1.75 510% upside
• High target: $2 598% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Scotiabank Sung Ji Nam	598% upside $2	Sector Outperform Maintained	21 May 2025
Craig-Hallum Bill Bonello	423% upside $1.50	Buy Maintained	14 May 2025
Lake Street Thomas Flaten	598% upside $2	Buy Maintained	14 May 2025
Canaccord Genuity Kyle Mikson	423% upside $1.50	Buy Maintained	14 May 2025